A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM).
Chetana Prakash DeshmukhNarendra KumarPravin SalunkeChirag AhujaRenu MadanPublished in: Asian Pacific journal of cancer prevention : APJCP (2022)
We concluded that adding temozolomide to short-course radiotherapy significantly improved progression-free survival and showed an increasing trend in overall survival without compromising the quality of life.